Docetaxel-carboplatin in combination with erlotinib and/or bevacizumab in patients with non-small cell lung cancer

Overview of attention for article published in OncoTargets and therapy, March 2013

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 41 Dimensions

Readers on

mendeley: 40 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 3,712 followers.

[VEGF] Docetaxel-carboplatin in combination with erlotinib and/or bevacizumab in patients with non-small ce... http://t.co/U7qbQkdOdZ PM

Reply Repost Favourite

#DocetaxelCarboplatin in combination with #erlotinib or #bevacizumab in #patients with #nNonSmallCell #LungCancer: http://t.co/QUj4C1GKY0

Reply Repost Favourite